Effect of Aprotinin and Avifavir^® Combination Therapy for Moderate COVID-19 Patients

COVID-19 is a contagious multisystem inflammatory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We studied the efficacy of Aprotinin (nonspecific serine proteases inhibitor) in combination with Avifavir^® or Hydroxychloroquine (HCQ) drugs, which are reco...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Andrey A. Ivashchenko, Valeria N. Azarova, Alina N. Egorova, Ruben N. Karapetian, Dmitry V. Kravchenko, Natalia V. Krivonos, Vladimir G. Loginov, Stanislav V. Poyarkov, Elena A. Merkulova, Olga S. Rosinkova, Nikolay P. Savchuk, Mikhail A. Topr, Elena N. Simakina, Elena V. Yakubova, Alexandre V. Ivachtchenko
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2021-06-01
סדרה:	Viruses
נושאים:	COVID-19 SARS-CoV-2 aprotinin favipiravir
גישה מקוונת:	https://www.mdpi.com/1999-4915/13/7/1253
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!